Appili Therapeutics Inc. (TSXV:APLI, OTCQX:APLIF) (the Company or Appili), a biopharmaceutical company developing anti-infective drug candidates, today announced that its leadership team will be presenting…
Entasis Therapeutics to Participate in Upcoming Healthcare Investor Conferences
The MarketWatch News Department was not involved in the creation of this content. WALTHAM, Mass., Sep 10, 2020 (GLOBE NEWSWIRE via COMTEX) — WALTHAM, Mass.,…
Prevail Therapeutics to Present at Upcoming Investor Conferences
NEW YORK, Sept. 25, 2020 (GLOBE NEWSWIRE) — Prevail Therapeutics Inc. (Nasdaq: PRVL), a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients with…
Frequency Therapeutics to Present at Upcoming Investor Conferences and Medical Meetings
Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused by a broad…